The lung cancer surgery market is a critical segment within the broader oncology market, driven by the increasing incidence of lung cancer worldwide. Lung cancer is one of the most common and deadly forms of cancer, with both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) being prevalent. Surgical intervention remains one of the most effective treatments, especially in the...